Scholars Central

Editor

Arun Srivastava

Professor, Department of Genetics, University of Florida, USA

About

As published by the journal they serve.

Dr. Arun Srivastava is Chief of Division of Cellular & Molecular Therapy in the Departments of Pediatrics, and Molecular Genetics & Microbiology, and Powell Gene Therapy Center. He has also served as Assistant Director of the UF General Clinical Research Center. He received his PhD degree from the Indian Institute of Science in Bangalore, India. After completing his postdoctoral training at the Memorial Sloan-Kettering Cancer Center in New York, he worked as a Research Associate at the University of Florida. For nearly two decades, he was on the faculty at Indiana University School of Medicine in Indianapolis, where he rose to the rank of Professor. He was recruited back to the University of Florida in 2004. In the past three decades, he has mentored 8 Clinical Fellows and 32 Postdoctoral Fellows. Two students have graduated with MS degrees, and 7 students have received their PhD degrees from his laboratory. His research activities are currently supported by grants from the National Institutes of Health and the Bayer Hemophilia Program. He has also been awarded 3 US Patents on his research on human parvoviruses and their potential use as vectors in human gene therapy. He currently serves on two NIH Study Sections as well as on the Editorial Boards of Journal of Virology, Human Gene Therapy, Recent Patents on DNA and Gene Sequences, Gene Therapy and Molecular Biology, and Journal of Chinese Integrative Medicine. He has published 157 research articles, mostly on human parvoviruses, in peer-reviewed journals, reviews, and book chapters.

Research interests

  • For the past 30 years
  • Dr. Srivastava’s research has been focused on the following two parvoviruses
  • the non-pathogenic adeno-associated virus (AAV)
  • and a common human pathogen
  • the parvovirus B19
  • which include: identification of cellular co-receptors for AAV2
  • AAV3 as well as parvovirus B19
  • development of recombinant AAV and parvovirus B19 vectors
  • and transgenic and knockout mouse models to study parvovirus-induced pathogenicity
  • and the use of parvovirus vectors for gene transfer and gene therapy. More recently
  • and malignant disorders such as hepatoblastoma and hepatocellular carcinoma

Journals they serve

The seats these journals name them in.

Articles we hold

Articles in the journals they serve whose byline carries this name.

This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.